Healthcare provider profile · identity verified

Arthur A Kornbluth, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology · NEW YORK, NY · NPI 1104835784

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Arthur A Kornbluth, MD received $292,756.07 in general payments during 2025 across 431 reported records.

Janssen Biotech, Inc. accounted for 33.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 23 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Stelara, Xifaxan.

Janssen Biotech, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported STELARA as an associated drug or biological on 23706 records involving 7279 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Stelara by this doctor in 2024.

Janssen Scientific Affairs, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported STELARA as an associated drug or biological on 233 records involving 190 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Stelara by this doctor in 2024.

Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Xifaxan by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$292,756.07

431 reported records · 18 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Janssen Biotech, Inc.	Unresolved — no canonical attribution shown	$98,452.81	33.6%	106	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$77,938.25	26.6%	68	2025
ABBVIE INC.	Unresolved — no canonical attribution shown	$69,137.43	23.6%	122	2025
Takeda Pharmaceuticals U.S.A., Inc.	Unresolved — no canonical attribution shown	$21,902.90	7.5%	51	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$14,397.41	4.9%	29	2025
Celltrion USA Inc.	Unresolved — no canonical attribution shown	$9,800.31	3.4%	8	2025
Janssen Scientific Affairs, LLC	Unresolved — no canonical attribution shown	$429.67	0.1%	3	2025
Salix Pharmaceuticals, a division of Bausch Health US, LLC	Unresolved — no canonical attribution shown	$172.09	0.1%	17	2025
Regeneron Healthcare Solutions, Inc.	Unresolved — no canonical attribution shown	$77.70	0.0%	3	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$77.18	0.0%	4	2025
Organon LLC	Unresolved — no canonical attribution shown	$71.21	0.0%	3	2025
Ardelyx, Inc.	Unresolved — no canonical attribution shown	$64.91	0.0%	3	2025
Phathom Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$60.97	0.0%	7	2025
Aimmune Therapeutics, Inc.	Unresolved — no canonical attribution shown	$52.04	0.0%	3	2025
QOL Medical, LLC	Unresolved — no canonical attribution shown	$47.78	0.0%	1	2025
Sandoz Inc.	Unresolved — no canonical attribution shown	$29.15	0.0%	1	2025
VIVUS LLC	Unresolved — no canonical attribution shown	$23.36	0.0%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$20.90	0.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$238,526.50	100
Travel and Lodging	$30,088.76	45
Food and Beverage	$11,505.68	278
Honoraria	$8,455.63	6
Consulting Fee	$4,179.50	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
TREMFYA Normalized: tremfya	Drug	Janssen Biotech, Inc., Janssen Scientific Affairs, LLC	$98,882.48	109	2025
Source payment records 2025-01-06 · Janssen Biotech, Inc. · $27.18 · Open Payments source 2025-01-11 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-01-16 · Janssen Biotech, Inc. · $549.35 · Open Payments source 2025-01-16 · Janssen Biotech, Inc. · $150.00 · Open Payments source 2025-01-20 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-01-20 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-01-20 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-01-20 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-01-22 · Janssen Biotech, Inc. · $150.00 · Open Payments source 2025-01-22 · Janssen Biotech, Inc. · $848.39 · Open Payments source 2025-01-23 · Janssen Biotech, Inc. · $115.70 · Open Payments source 2025-01-23 · Janssen Biotech, Inc. · $872.75 · Open Payments source 2025-01-25 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-01-25 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-01-27 · Janssen Biotech, Inc. · $27.78 · Open Payments source 2025-01-28 · Janssen Biotech, Inc. · $150.00 · Open Payments source 2025-01-28 · Janssen Biotech, Inc. · $938.15 · Open Payments source 2025-01-30 · Janssen Biotech, Inc. · $661.06 · Open Payments source 2025-01-30 · Janssen Biotech, Inc. · $146.76 · Open Payments source 2025-02-01 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-02-01 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-02-01 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-02-01 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-02-05 · Janssen Biotech, Inc. · $784.22 · Open Payments source 2025-02-05 · Janssen Biotech, Inc. · $150.00 · Open Payments source 2025-02-08 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-02-08 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-02-11 · Janssen Biotech, Inc. · $28.80 · Open Payments source 2025-02-11 · Janssen Biotech, Inc. · $796.74 · Open Payments source 2025-02-11 · Janssen Biotech, Inc. · $149.29 · Open Payments source 2025-02-13 · Janssen Biotech, Inc. · $32.22 · Open Payments source 2025-02-15 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-02-15 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-02-28 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-02-28 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-03-08 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-03-08 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-03-22 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-03-22 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-03-24 · Janssen Biotech, Inc. · $20.49 · Open Payments source 2025-03-25 · Janssen Biotech, Inc. · $42.16 · Open Payments source 2025-03-29 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-03-31 · Janssen Biotech, Inc. · $17.65 · Open Payments source 2025-04-02 · Janssen Scientific Affairs, LLC · $133.33 · Open Payments source 2025-04-21 · Janssen Biotech, Inc. · $25.37 · Open Payments source 2025-04-23 · Janssen Biotech, Inc. · $111.81 · Open Payments source 2025-04-23 · Janssen Biotech, Inc. · $969.41 · Open Payments source 2025-04-24 · Janssen Biotech, Inc. · $21.00 · Open Payments source 2025-04-26 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-04-26 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-04-26 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-04-29 · Janssen Biotech, Inc. · $14.68 · Open Payments source 2025-04-29 · Janssen Biotech, Inc. · $148.72 · Open Payments source 2025-04-29 · Janssen Biotech, Inc. · $999.83 · Open Payments source 2025-05-01 · Janssen Biotech, Inc. · $141.76 · Open Payments source 2025-05-01 · Janssen Biotech, Inc. · $464.64 · Open Payments source 2025-05-03 · Janssen Biotech, Inc. · $563.00 · Open Payments source 2025-05-03 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-05-03 · Janssen Biotech, Inc. · $46.98 · Open Payments source 2025-05-03 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-05-03 · Janssen Biotech, Inc. · $38.92 · Open Payments source 2025-05-07 · Janssen Biotech, Inc. · $15.68 · Open Payments source 2025-05-10 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-05-10 · Janssen Biotech, Inc. · $3,000.00 · Open Payments source 2025-05-12 · Janssen Biotech, Inc. · $22.97 · Open Payments source 2025-05-16 · Janssen Biotech, Inc. · $3.63 · Open Payments source 2025-05-16 · Janssen Biotech, Inc. · $5.06 · Open Payments source 2025-05-17 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-05-17 · Janssen Biotech, Inc. · $2,250.00 · Open Payments source 2025-05-21 · Janssen Biotech, Inc. · $872.98 · Open Payments source 2025-05-21 · Janssen Biotech, Inc. · $97.84 · Open Payments source 2025-05-22 · Janssen Biotech, Inc. · $795.87 · Open Payments source 2025-05-22 · Janssen Biotech, Inc. · $144.35 · Open Payments source 2025-05-23 · Janssen Biotech, Inc. · $19.23 · Open Payments source 2025-05-24 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-05-24 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-05-24 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-05-27 · Janssen Biotech, Inc. · $26.09 · Open Payments source 2025-05-29 · Janssen Biotech, Inc. · $125.00 · Open Payments source 2025-05-29 · Janssen Biotech, Inc. · $401.18 · Open Payments source 2025-05-31 · Janssen Biotech, Inc. · $3,375.00 · Open Payments source 2025-06-11 · Janssen Biotech, Inc. · $21.53 · Open Payments source 2025-06-19 · Janssen Biotech, Inc. · $2.26 · Open Payments source 2025-06-19 · Janssen Biotech, Inc. · $21.19 · Open Payments source 2025-06-20 · Janssen Biotech, Inc. · $11.49 · Open Payments source 2025-06-20 · Janssen Biotech, Inc. · $1.96 · Open Payments source 2025-06-28 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-07-05 · Janssen Biotech, Inc. · $938.00 · Open Payments source 2025-07-07 · Janssen Biotech, Inc. · $147.33 · Open Payments source 2025-07-16 · Janssen Biotech, Inc. · $20.58 · Open Payments source 2025-07-21 · Janssen Biotech, Inc. · $33.24 · Open Payments source 2025-07-25 · Janssen Biotech, Inc. · $37.11 · Open Payments source 2025-08-05 · Janssen Biotech, Inc. · $23.07 · Open Payments source 2025-08-06 · Janssen Scientific Affairs, LLC · $150.00 · Open Payments source 2025-08-08 · Janssen Biotech, Inc. · $19.27 · Open Payments source 2025-08-15 · Janssen Biotech, Inc. · $35.44 · Open Payments source 2025-08-25 · Janssen Biotech, Inc. · $27.09 · Open Payments source 2025-09-18 · Janssen Biotech, Inc. · $27.96 · Open Payments source 2025-09-22 · Janssen Biotech, Inc. · $25.24 · Open Payments source 2025-09-29 · Janssen Biotech, Inc. · $27.58 · Open Payments source 2025-10-23 · Janssen Biotech, Inc. · $38.52 · Open Payments source 2025-10-25 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source 2025-11-14 · Janssen Biotech, Inc. · $37.65 · Open Payments source 2025-12-03 · Janssen Scientific Affairs, LLC · $146.34 · Open Payments source 2025-12-08 · Janssen Biotech, Inc. · $140.60 · Open Payments source 2025-12-09 · Janssen Biotech, Inc. · $14.67 · Open Payments source 2025-12-11 · Janssen Biotech, Inc. · $37.66 · Open Payments source 2025-12-22 · Janssen Biotech, Inc. · $25.94 · Open Payments source 2025-12-23 · Janssen Biotech, Inc. · $2.74 · Open Payments source
OMVOH Normalized: omvoh	Drug	Lilly USA, LLC	$69,994.55	55	2025
Source payment records 2025-01-13 · Lilly USA, LLC · $125.00 · Open Payments source 2025-01-15 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-01-15 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-01-20 · Lilly USA, LLC · $24.34 · Open Payments source 2025-01-20 · Lilly USA, LLC · $1.56 · Open Payments source 2025-01-27 · Lilly USA, LLC · $116.65 · Open Payments source 2025-01-30 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-01-30 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-02-19 · Lilly USA, LLC · $125.00 · Open Payments source 2025-02-21 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-02-21 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-02-24 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-02-25 · Lilly USA, LLC · $0.88 · Open Payments source 2025-02-25 · Lilly USA, LLC · $119.96 · Open Payments source 2025-02-25 · Lilly USA, LLC · $28.17 · Open Payments source 2025-02-26 · Lilly USA, LLC · $97.99 · Open Payments source 2025-02-27 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-02-27 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-02-28 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-02-28 · Lilly USA, LLC · $2,000.00 · Open Payments source 2025-03-06 · Lilly USA, LLC · $125.01 · Open Payments source 2025-03-10 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-03-11 · Lilly USA, LLC · $22.87 · Open Payments source 2025-04-01 · Lilly USA, LLC · $119.98 · Open Payments source 2025-04-03 · Lilly USA, LLC · $122.19 · Open Payments source 2025-04-04 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-04-04 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-04-07 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-04-07 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-04-08 · Lilly USA, LLC · $2.49 · Open Payments source 2025-04-08 · Lilly USA, LLC · $30.28 · Open Payments source 2025-06-04 · Lilly USA, LLC · $118.71 · Open Payments source 2025-06-06 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-06-06 · Lilly USA, LLC · $2,000.00 · Open Payments source 2025-06-24 · Lilly USA, LLC · $119.99 · Open Payments source 2025-06-27 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-06-27 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-07-14 · Lilly USA, LLC · $2.68 · Open Payments source 2025-07-14 · Lilly USA, LLC · $19.97 · Open Payments source 2025-07-15 · Lilly USA, LLC · $120.03 · Open Payments source 2025-07-15 · Lilly USA, LLC · $2.00 · Open Payments source 2025-07-17 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-07-17 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-08-15 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-08-15 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-08-18 · Lilly USA, LLC · $2.75 · Open Payments source 2025-08-18 · Lilly USA, LLC · $25.55 · Open Payments source 2025-08-18 · Lilly USA, LLC · $0.25 · Open Payments source 2025-09-11 · Lilly USA, LLC · $120.25 · Open Payments source 2025-09-15 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-09-15 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-09-19 · Lilly USA, LLC · $1,600.00 · Open Payments source 2025-09-30 · Lilly USA, LLC · $1,200.00 · Open Payments source 2025-09-30 · Lilly USA, LLC · $3,200.00 · Open Payments source 2025-10-14 · Lilly USA, LLC · $1,600.00 · Open Payments source
SKYRIZI Normalized: skyrizi	Biological	ABBVIE INC.	$43,099.45	98	2025
Source payment records 2025-01-06 · ABBVIE INC. · $23.67 · Open Payments source 2025-01-15 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-01-18 · ABBVIE INC. · $18.32 · Open Payments source 2025-01-22 · ABBVIE INC. · $24.94 · Open Payments source 2025-01-22 · ABBVIE INC. · $4.58 · Open Payments source 2025-01-22 · ABBVIE INC. · $24.13 · Open Payments source 2025-02-01 · ABBVIE INC. · $12.79 · Open Payments source 2025-02-03 · ABBVIE INC. · $22.90 · Open Payments source 2025-02-04 · ABBVIE INC. · $5.96 · Open Payments source 2025-02-04 · ABBVIE INC. · $126.85 · Open Payments source 2025-02-04 · ABBVIE INC. · $946.63 · Open Payments source 2025-02-18 · ABBVIE INC. · $110.35 · Open Payments source 2025-02-18 · ABBVIE INC. · $786.74 · Open Payments source 2025-02-19 · ABBVIE INC. · $21.48 · Open Payments source 2025-02-19 · ABBVIE INC. · $22.73 · Open Payments source 2025-02-20 · ABBVIE INC. · $3.81 · Open Payments source 2025-02-20 · ABBVIE INC. · $122.78 · Open Payments source 2025-02-20 · ABBVIE INC. · $762.74 · Open Payments source 2025-02-27 · ABBVIE INC. · $15.40 · Open Payments source 2025-03-05 · ABBVIE INC. · $21.88 · Open Payments source 2025-03-12 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-03-14 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-03-14 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-03-20 · ABBVIE INC. · $124.28 · Open Payments source 2025-03-20 · ABBVIE INC. · $734.93 · Open Payments source 2025-03-25 · ABBVIE INC. · $125.00 · Open Payments source 2025-03-25 · ABBVIE INC. · $881.31 · Open Payments source 2025-03-27 · ABBVIE INC. · $118.62 · Open Payments source 2025-03-27 · ABBVIE INC. · $749.15 · Open Payments source 2025-03-28 · ABBVIE INC. · $1,250.00 · Open Payments source 2025-03-29 · ABBVIE INC. · $24.93 · Open Payments source 2025-04-02 · ABBVIE INC. · $22.31 · Open Payments source 2025-04-07 · ABBVIE INC. · $19.93 · Open Payments source 2025-04-09 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-04-11 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-04-11 · ABBVIE INC. · $4,375.00 · Open Payments source 2025-04-15 · ABBVIE INC. · $34.15 · Open Payments source 2025-04-17 · ABBVIE INC. · $432.58 · Open Payments source 2025-04-17 · ABBVIE INC. · $124.02 · Open Payments source 2025-04-22 · ABBVIE INC. · $26.22 · Open Payments source 2025-04-26 · ABBVIE INC. · $11.39 · Open Payments source 2025-04-29 · ABBVIE INC. · $1.73 · Open Payments source 2025-04-29 · ABBVIE INC. · $28.16 · Open Payments source 2025-05-08 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-05-13 · ABBVIE INC. · $24.00 · Open Payments source 2025-05-13 · ABBVIE INC. · $1.77 · Open Payments source 2025-05-15 · ABBVIE INC. · $23.71 · Open Payments source 2025-05-15 · ABBVIE INC. · $3.59 · Open Payments source 2025-05-28 · ABBVIE INC. · $23.45 · Open Payments source 2025-05-28 · ABBVIE INC. · $1.19 · Open Payments source 2025-06-10 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-06-25 · ABBVIE INC. · $30.31 · Open Payments source 2025-06-26 · ABBVIE INC. · $23.87 · Open Payments source 2025-07-08 · ABBVIE INC. · $92.37 · Open Payments source 2025-07-08 · ABBVIE INC. · $11.45 · Open Payments source 2025-07-09 · ABBVIE INC. · $2.00 · Open Payments source 2025-07-09 · ABBVIE INC. · $20.36 · Open Payments source 2025-07-11 · ABBVIE INC. · $17.39 · Open Payments source 2025-07-16 · ABBVIE INC. · $19.80 · Open Payments source 2025-07-16 · ABBVIE INC. · $1.58 · Open Payments source 2025-07-16 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-07-25 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-07-29 · ABBVIE INC. · $2.78 · Open Payments source 2025-07-29 · ABBVIE INC. · $24.67 · Open Payments source 2025-08-09 · ABBVIE INC. · $10.69 · Open Payments source 2025-08-13 · ABBVIE INC. · $23.47 · Open Payments source 2025-08-19 · ABBVIE INC. · $32.01 · Open Payments source 2025-08-21 · ABBVIE INC. · $5.44 · Open Payments source 2025-08-21 · ABBVIE INC. · $22.50 · Open Payments source 2025-09-04 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-09-04 · ABBVIE INC. · $24.51 · Open Payments source 2025-09-13 · ABBVIE INC. · $20.50 · Open Payments source 2025-09-17 · ABBVIE INC. · $23.22 · Open Payments source 2025-09-17 · ABBVIE INC. · $2.04 · Open Payments source 2025-10-01 · ABBVIE INC. · $2.06 · Open Payments source 2025-10-01 · ABBVIE INC. · $23.66 · Open Payments source 2025-10-06 · ABBVIE INC. · $6.44 · Open Payments source 2025-10-07 · ABBVIE INC. · $1.45 · Open Payments source 2025-10-07 · ABBVIE INC. · $21.99 · Open Payments source 2025-10-22 · ABBVIE INC. · $2.75 · Open Payments source 2025-10-22 · ABBVIE INC. · $28.07 · Open Payments source 2025-11-05 · ABBVIE INC. · $26.07 · Open Payments source 2025-11-05 · ABBVIE INC. · $2.71 · Open Payments source 2025-11-06 · ABBVIE INC. · $21.60 · Open Payments source 2025-11-06 · ABBVIE INC. · $4.93 · Open Payments source 2025-11-07 · ABBVIE INC. · $15.44 · Open Payments source 2025-11-11 · ABBVIE INC. · $28.51 · Open Payments source 2025-11-18 · ABBVIE INC. · $2.77 · Open Payments source 2025-11-18 · ABBVIE INC. · $28.98 · Open Payments source 2025-11-18 · ABBVIE INC. · $29.44 · Open Payments source 2025-11-26 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-11-27 · ABBVIE INC. · $22.17 · Open Payments source 2025-12-03 · ABBVIE INC. · $28.78 · Open Payments source 2025-12-05 · ABBVIE INC. · $14.52 · Open Payments source 2025-12-08 · ABBVIE INC. · $98.29 · Open Payments source 2025-12-12 · ABBVIE INC. · $10.54 · Open Payments source 2025-12-16 · ABBVIE INC. · $1.88 · Open Payments source 2025-12-16 · ABBVIE INC. · $25.34 · Open Payments source
RINVOQ Normalized: rinvoq	Biological	ABBVIE INC.	$26,759.94	65	2025
Source payment records 2025-01-13 · ABBVIE INC. · $29.27 · Open Payments source 2025-01-18 · ABBVIE INC. · $18.32 · Open Payments source 2025-01-22 · ABBVIE INC. · $24.94 · Open Payments source 2025-02-19 · ABBVIE INC. · $22.73 · Open Payments source 2025-02-27 · ABBVIE INC. · $15.40 · Open Payments source 2025-03-04 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-04-02 · ABBVIE INC. · $22.31 · Open Payments source 2025-04-07 · ABBVIE INC. · $19.93 · Open Payments source 2025-04-22 · ABBVIE INC. · $26.22 · Open Payments source 2025-04-29 · ABBVIE INC. · $28.16 · Open Payments source 2025-05-08 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-05-13 · ABBVIE INC. · $24.00 · Open Payments source 2025-05-13 · ABBVIE INC. · $1.77 · Open Payments source 2025-05-15 · ABBVIE INC. · $23.71 · Open Payments source 2025-05-28 · ABBVIE INC. · $23.45 · Open Payments source 2025-05-28 · ABBVIE INC. · $1.19 · Open Payments source 2025-06-25 · ABBVIE INC. · $30.31 · Open Payments source 2025-06-26 · ABBVIE INC. · $23.87 · Open Payments source 2025-07-08 · ABBVIE INC. · $11.45 · Open Payments source 2025-07-09 · ABBVIE INC. · $2.00 · Open Payments source 2025-07-09 · ABBVIE INC. · $20.36 · Open Payments source 2025-07-11 · ABBVIE INC. · $17.39 · Open Payments source 2025-07-16 · ABBVIE INC. · $19.80 · Open Payments source 2025-07-16 · ABBVIE INC. · $1.58 · Open Payments source 2025-07-29 · ABBVIE INC. · $2.78 · Open Payments source 2025-07-29 · ABBVIE INC. · $24.67 · Open Payments source 2025-08-06 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-08-09 · ABBVIE INC. · $10.69 · Open Payments source 2025-08-13 · ABBVIE INC. · $23.47 · Open Payments source 2025-08-19 · ABBVIE INC. · $32.01 · Open Payments source 2025-08-21 · ABBVIE INC. · $5.44 · Open Payments source 2025-08-21 · ABBVIE INC. · $22.50 · Open Payments source 2025-08-21 · ABBVIE INC. · $1,875.00 · Open Payments source 2025-09-02 · ABBVIE INC. · $1,562.50 · Open Payments source 2025-09-04 · ABBVIE INC. · $24.51 · Open Payments source 2025-09-16 · ABBVIE INC. · $144.86 · Open Payments source 2025-09-16 · ABBVIE INC. · $777.59 · Open Payments source 2025-09-17 · ABBVIE INC. · $23.22 · Open Payments source 2025-09-17 · ABBVIE INC. · $2.04 · Open Payments source 2025-09-29 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-10-06 · ABBVIE INC. · $6.44 · Open Payments source 2025-10-07 · ABBVIE INC. · $1.45 · Open Payments source 2025-10-07 · ABBVIE INC. · $21.99 · Open Payments source 2025-10-09 · ABBVIE INC. · $125.00 · Open Payments source 2025-10-09 · ABBVIE INC. · $690.95 · Open Payments source 2025-10-22 · ABBVIE INC. · $2.75 · Open Payments source 2025-10-22 · ABBVIE INC. · $28.07 · Open Payments source 2025-10-29 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-10-29 · ABBVIE INC. · $130.92 · Open Payments source 2025-10-29 · ABBVIE INC. · $598.17 · Open Payments source 2025-11-05 · ABBVIE INC. · $26.07 · Open Payments source 2025-11-05 · ABBVIE INC. · $2.71 · Open Payments source 2025-11-06 · ABBVIE INC. · $21.60 · Open Payments source 2025-11-07 · ABBVIE INC. · $15.44 · Open Payments source 2025-11-13 · ABBVIE INC. · $125.00 · Open Payments source 2025-11-13 · ABBVIE INC. · $539.02 · Open Payments source 2025-11-18 · ABBVIE INC. · $2.77 · Open Payments source 2025-11-18 · ABBVIE INC. · $28.98 · Open Payments source 2025-11-18 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-11-27 · ABBVIE INC. · $22.17 · Open Payments source 2025-12-03 · ABBVIE INC. · $28.78 · Open Payments source 2025-12-04 · ABBVIE INC. · $3,125.00 · Open Payments source 2025-12-16 · ABBVIE INC. · $1.88 · Open Payments source 2025-12-16 · ABBVIE INC. · $25.34 · Open Payments source 2025-12-18 · ABBVIE INC. · $1,250.00 · Open Payments source
ENTYVIO Normalized: entyvio	Biological	Takeda Pharmaceuticals U.S.A., Inc.	$21,879.80	50	2025
Source payment records 2025-01-02 · Takeda Pharmaceuticals U.S.A., Inc. · $1.11 · Open Payments source 2025-01-02 · Takeda Pharmaceuticals U.S.A., Inc. · $24.86 · Open Payments source 2025-01-13 · Takeda Pharmaceuticals U.S.A., Inc. · $24.95 · Open Payments source 2025-01-16 · Takeda Pharmaceuticals U.S.A., Inc. · $1,179.50 · Open Payments source 2025-02-13 · Takeda Pharmaceuticals U.S.A., Inc. · $129.02 · Open Payments source 2025-02-13 · Takeda Pharmaceuticals U.S.A., Inc. · $653.39 · Open Payments source 2025-02-21 · Takeda Pharmaceuticals U.S.A., Inc. · $26.73 · Open Payments source 2025-02-24 · Takeda Pharmaceuticals U.S.A., Inc. · $1.42 · Open Payments source 2025-02-24 · Takeda Pharmaceuticals U.S.A., Inc. · $31.95 · Open Payments source 2025-03-06 · Takeda Pharmaceuticals U.S.A., Inc. · $3,033.00 · Open Payments source 2025-03-17 · Takeda Pharmaceuticals U.S.A., Inc. · $1.09 · Open Payments source 2025-03-17 · Takeda Pharmaceuticals U.S.A., Inc. · $1.85 · Open Payments source 2025-03-18 · Takeda Pharmaceuticals U.S.A., Inc. · $19.37 · Open Payments source 2025-03-19 · Takeda Pharmaceuticals U.S.A., Inc. · $107.99 · Open Payments source 2025-03-19 · Takeda Pharmaceuticals U.S.A., Inc. · $100.00 · Open Payments source 2025-03-19 · Takeda Pharmaceuticals U.S.A., Inc. · $859.18 · Open Payments source 2025-03-25 · Takeda Pharmaceuticals U.S.A., Inc. · $1.79 · Open Payments source 2025-03-25 · Takeda Pharmaceuticals U.S.A., Inc. · $28.75 · Open Payments source 2025-03-31 · Takeda Pharmaceuticals U.S.A., Inc. · $1.15 · Open Payments source 2025-03-31 · Takeda Pharmaceuticals U.S.A., Inc. · $26.18 · Open Payments source 2025-04-09 · Takeda Pharmaceuticals U.S.A., Inc. · $4,381.00 · Open Payments source 2025-04-22 · Takeda Pharmaceuticals U.S.A., Inc. · $24.67 · Open Payments source 2025-05-19 · Takeda Pharmaceuticals U.S.A., Inc. · $26.10 · Open Payments source 2025-05-20 · Takeda Pharmaceuticals U.S.A., Inc. · $1.04 · Open Payments source 2025-05-20 · Takeda Pharmaceuticals U.S.A., Inc. · $18.55 · Open Payments source 2025-06-23 · Takeda Pharmaceuticals U.S.A., Inc. · $33.42 · Open Payments source 2025-08-01 · Takeda Pharmaceuticals U.S.A., Inc. · $50.00 · Open Payments source 2025-08-01 · Takeda Pharmaceuticals U.S.A., Inc. · $804.66 · Open Payments source 2025-08-05 · Takeda Pharmaceuticals U.S.A., Inc. · $3.17 · Open Payments source 2025-08-05 · Takeda Pharmaceuticals U.S.A., Inc. · $23.33 · Open Payments source 2025-08-11 · Takeda Pharmaceuticals U.S.A., Inc. · $32.86 · Open Payments source 2025-09-15 · Takeda Pharmaceuticals U.S.A., Inc. · $1,685.00 · Open Payments source 2025-09-16 · Takeda Pharmaceuticals U.S.A., Inc. · $1.76 · Open Payments source 2025-09-16 · Takeda Pharmaceuticals U.S.A., Inc. · $2.64 · Open Payments source 2025-09-16 · Takeda Pharmaceuticals U.S.A., Inc. · $31.43 · Open Payments source 2025-09-18 · Takeda Pharmaceuticals U.S.A., Inc. · $112.84 · Open Payments source 2025-09-18 · Takeda Pharmaceuticals U.S.A., Inc. · $710.67 · Open Payments source 2025-09-29 · Takeda Pharmaceuticals U.S.A., Inc. · $1.39 · Open Payments source 2025-09-29 · Takeda Pharmaceuticals U.S.A., Inc. · $21.73 · Open Payments source 2025-10-08 · Takeda Pharmaceuticals U.S.A., Inc. · $4,381.00 · Open Payments source 2025-10-13 · Takeda Pharmaceuticals U.S.A., Inc. · $30.14 · Open Payments source 2025-10-30 · Takeda Pharmaceuticals U.S.A., Inc. · $124.12 · Open Payments source 2025-11-03 · Takeda Pharmaceuticals U.S.A., Inc. · $1.89 · Open Payments source 2025-11-03 · Takeda Pharmaceuticals U.S.A., Inc. · $22.74 · Open Payments source 2025-11-17 · Takeda Pharmaceuticals U.S.A., Inc. · $3,033.00 · Open Payments source 2025-12-01 · Takeda Pharmaceuticals U.S.A., Inc. · $0.41 · Open Payments source 2025-12-01 · Takeda Pharmaceuticals U.S.A., Inc. · $2.61 · Open Payments source 2025-12-01 · Takeda Pharmaceuticals U.S.A., Inc. · $28.89 · Open Payments source 2025-12-23 · Takeda Pharmaceuticals U.S.A., Inc. · $4.43 · Open Payments source 2025-12-23 · Takeda Pharmaceuticals U.S.A., Inc. · $31.03 · Open Payments source
VELSIPITY Normalized: velsipity	Drug	PFIZER INC.	$14,397.41	29	2025
Source payment records 2025-03-10 · PFIZER INC. · $18.24 · Open Payments source 2025-03-21 · PFIZER INC. · $28.74 · Open Payments source 2025-04-08 · PFIZER INC. · $29.57 · Open Payments source 2025-04-28 · PFIZER INC. · $19.52 · Open Payments source 2025-05-13 · PFIZER INC. · $21.96 · Open Payments source 2025-06-24 · PFIZER INC. · $23.92 · Open Payments source 2025-08-04 · PFIZER INC. · $26.05 · Open Payments source 2025-08-04 · PFIZER INC. · $2.45 · Open Payments source 2025-08-14 · PFIZER INC. · $113.58 · Open Payments source 2025-08-19 · PFIZER INC. · $380.37 · Open Payments source 2025-08-21 · PFIZER INC. · $4,275.00 · Open Payments source 2025-09-15 · PFIZER INC. · $26.96 · Open Payments source 2025-09-16 · PFIZER INC. · $1.62 · Open Payments source 2025-09-29 · PFIZER INC. · $125.00 · Open Payments source 2025-10-02 · PFIZER INC. · $732.41 · Open Payments source 2025-10-02 · PFIZER INC. · $4,275.00 · Open Payments source 2025-10-06 · PFIZER INC. · $28.69 · Open Payments source 2025-10-06 · PFIZER INC. · $1.00 · Open Payments source 2025-10-07 · PFIZER INC. · $0.21 · Open Payments source 2025-10-13 · PFIZER INC. · $9.81 · Open Payments source 2025-10-20 · PFIZER INC. · $9.70 · Open Payments source 2025-11-03 · PFIZER INC. · $25.82 · Open Payments source 2025-11-08 · PFIZER INC. · $7.60 · Open Payments source 2025-11-20 · PFIZER INC. · $27.40 · Open Payments source 2025-11-25 · PFIZER INC. · $25.69 · Open Payments source 2025-11-26 · PFIZER INC. · $1.98 · Open Payments source 2025-12-10 · PFIZER INC. · $4,125.00 · Open Payments source 2025-12-18 · PFIZER INC. · $24.84 · Open Payments source 2025-12-23 · PFIZER INC. · $9.28 · Open Payments source
ZYMFENTRA Normalized: zymfentra	Biological	Celltrion USA Inc.	$9,800.31	8	2025
Source payment records 2025-05-02 · Celltrion USA Inc. · $1,222.50 · Open Payments source 2025-05-20 · Celltrion USA Inc. · $122.18 · Open Payments source 2025-05-20 · Celltrion USA Inc. · $3,260.00 · Open Payments source 2025-06-04 · Celltrion USA Inc. · $1,222.50 · Open Payments source 2025-06-25 · Celltrion USA Inc. · $1,222.50 · Open Payments source 2025-07-09 · Celltrion USA Inc. · $1,222.50 · Open Payments source 2025-11-20 · Celltrion USA Inc. · $1,222.50 · Open Payments source 2025-12-18 · Celltrion USA Inc. · $305.63 · Open Payments source
STELARA Normalized: stelara	Biological	Janssen Biotech, Inc.	$3,001.00	3	2025
Source payment records 2025-05-03 · Janssen Biotech, Inc. · $563.00 · Open Payments source 2025-07-05 · Janssen Biotech, Inc. · $938.00 · Open Payments source 2025-10-25 · Janssen Biotech, Inc. · $1,500.00 · Open Payments source
XIFAXAN Normalized: xifaxan	Drug	Salix Pharmaceuticals, a division of Bausch Health US, LLC	$172.09	17	2025
Source payment records 2025-02-12 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $1.71 · Open Payments source 2025-02-12 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $15.46 · Open Payments source 2025-02-12 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $9.95 · Open Payments source 2025-02-12 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $1.67 · Open Payments source 2025-04-02 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $1.17 · Open Payments source 2025-04-02 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $20.24 · Open Payments source 2025-04-07 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $2.89 · Open Payments source 2025-04-07 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $1.00 · Open Payments source 2025-04-07 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $16.11 · Open Payments source 2025-05-05 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $24.52 · Open Payments source 2025-05-19 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $1.80 · Open Payments source 2025-05-19 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $14.71 · Open Payments source 2025-07-28 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $21.15 · Open Payments source 2025-07-28 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $1.54 · Open Payments source 2025-10-20 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $15.53 · Open Payments source 2025-11-17 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $1.45 · Open Payments source 2025-11-17 · Salix Pharmaceuticals, a division of Bausch Health US, LLC · $21.19 · Open Payments source
XELJANZ Normalized: xeljanz	Drug	PFIZER INC.	$141.95	6	2025
Source payment records 2025-03-10 · PFIZER INC. · $18.24 · Open Payments source 2025-03-21 · PFIZER INC. · $28.74 · Open Payments source 2025-04-08 · PFIZER INC. · $29.57 · Open Payments source 2025-04-28 · PFIZER INC. · $19.52 · Open Payments source 2025-05-13 · PFIZER INC. · $21.96 · Open Payments source 2025-06-24 · PFIZER INC. · $23.92 · Open Payments source
DUPIXENT Normalized: dupixent	Biological	Regeneron Healthcare Solutions, Inc.	$77.70	3	2025
Source payment records 2025-02-25 · Regeneron Healthcare Solutions, Inc. · $17.06 · Open Payments source 2025-08-17 · Regeneron Healthcare Solutions, Inc. · $30.32 · Open Payments source 2025-11-03 · Regeneron Healthcare Solutions, Inc. · $30.32 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$77.18	4	2025
Source payment records 2025-02-14 · Exact Sciences Corporation · $23.47 · Open Payments source 2025-05-20 · Exact Sciences Corporation · $19.49 · Open Payments source 2025-06-10 · Exact Sciences Corporation · $20.21 · Open Payments source 2025-10-27 · Exact Sciences Corporation · $14.01 · Open Payments source
HADLIMA Normalized: hadlima	Drug	Organon LLC	$71.21	3	2025
Source payment records 2025-01-07 · Organon LLC · $20.11 · Open Payments source 2025-06-09 · Organon LLC · $25.24 · Open Payments source 2025-07-29 · Organon LLC · $25.86 · Open Payments source
IBSRELA Normalized: ibsrela	Drug	Ardelyx, Inc.	$64.91	3	2025
Source payment records 2025-08-21 · Ardelyx, Inc. · $17.59 · Open Payments source 2025-10-13 · Ardelyx, Inc. · $29.55 · Open Payments source 2025-12-19 · Ardelyx, Inc. · $17.77 · Open Payments source
LINZESS Normalized: linzess	Drug	ABBVIE INC.	$64.70	5	2025
Source payment records 2025-01-14 · ABBVIE INC. · $8.69 · Open Payments source 2025-03-10 · ABBVIE INC. · $12.46 · Open Payments source 2025-05-01 · ABBVIE INC. · $22.14 · Open Payments source 2025-05-02 · ABBVIE INC. · $2.65 · Open Payments source 2025-10-01 · ABBVIE INC. · $18.76 · Open Payments source
VOQUEZNA Normalized: voquezna	Drug	Phathom Pharmaceuticals, Inc.	$60.97	7	2025
Source payment records 2025-02-25 · Phathom Pharmaceuticals, Inc. · $18.46 · Open Payments source 2025-02-25 · Phathom Pharmaceuticals, Inc. · $2.25 · Open Payments source 2025-03-18 · Phathom Pharmaceuticals, Inc. · $18.10 · Open Payments source 2025-03-18 · Phathom Pharmaceuticals, Inc. · $2.22 · Open Payments source 2025-03-19 · Phathom Pharmaceuticals, Inc. · $1.49 · Open Payments source 2025-10-28 · Phathom Pharmaceuticals, Inc. · $17.08 · Open Payments source 2025-10-29 · Phathom Pharmaceuticals, Inc. · $1.37 · Open Payments source
VOWST Normalized: vowst	Biological	Aimmune Therapeutics, Inc.	$52.04	3	2025
Source payment records 2025-01-31 · Aimmune Therapeutics, Inc. · $16.54 · Open Payments source 2025-02-21 · Aimmune Therapeutics, Inc. · $19.66 · Open Payments source 2025-10-04 · Aimmune Therapeutics, Inc. · $15.84 · Open Payments source
Sucraid Normalized: sucraid	Drug	QOL Medical, LLC	$47.78	1	2025
Source payment records 2025-12-16 · QOL Medical, LLC · $47.78 · Open Payments source
CREON Normalized: creon	Drug	ABBVIE INC.	$43.55	3	2025
Source payment records 2025-05-01 · ABBVIE INC. · $22.14 · Open Payments source 2025-05-02 · ABBVIE INC. · $2.65 · Open Payments source 2025-10-01 · ABBVIE INC. · $18.76 · Open Payments source
HYRIMOZ Normalized: hyrimoz	Biological	Sandoz Inc.	$29.15	1	2025
Source payment records 2025-11-22 · Sandoz Inc. · $29.15 · Open Payments source
QSYMIA Normalized: qsymia	Drug	VIVUS LLC	$23.36	1	2025
Source payment records 2025-01-10 · VIVUS LLC · $23.36 · Open Payments source
GATTEX Normalized: gattex	Drug	Takeda Pharmaceuticals U.S.A., Inc.	$23.10	1	2025
Source payment records 2025-08-15 · Takeda Pharmaceuticals U.S.A., Inc. · $23.10 · Open Payments source
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$20.90	1	2025
Source payment records 2025-04-04 · Novo Nordisk Inc · $20.90 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
STELARA stelara	2025	Stelara	2024	17 Beneficiary count suppressed	exact normalized	Medicare Part D
XIFAXAN xifaxan	2025	Xifaxan	2024	12 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Janssen Biotech, Inc. Exact reporting entity; no affiliate inference	2025	STELARA open payments reported associated product	CMS Open Payments — General Payments 23706 supporting records · 7279 recipient NPIs · example record 1174257377	Stelara · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
Janssen Scientific Affairs, LLC Exact reporting entity; no affiliate inference	2025	STELARA open payments reported associated product	CMS Open Payments — General Payments 233 supporting records · 190 recipient NPIs · example record 1174148007	Stelara · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference	2025	XIFAXAN open payments reported associated product	CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337	Xifaxan · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	26	suppressed
Mesalamine	Mesalamine	25	suppressed
Stelara	Ustekinumab	17	suppressed
Humira(Cf) Pen	Adalimumab	13	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	12	suppressed
Xifaxan	Rifaximin	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$292,756.07 · 431 records	Janssen Biotech, Inc.	CREON, Cologuard Collection Kit, DUPIXENT, ENTYVIO, GATTEX, HADLIMA, HYRIMOZ, IBSRELA, LINZESS, OMVOH, QSYMIA, RINVOQ, SKYRIZI, STELARA, Sucraid, TREMFYA, VELSIPITY, VOQUEZNA, VOWST, Wegovy, XELJANZ, XIFAXAN, ZYMFENTRA	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Stelara play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Janssen Biotech, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error